Global Influenza Vaccine Market Size to grow at a CAGR of 6.87% to reach USD 13,950.82 million by 2032, Evaluates DelveInsight

According to DelveInsight's analysis, The demand for influenza vaccines is mainly fueled by the rising global incidence of influenza, driven by the virus's easy transmission through cough and sneeze droplets. Increasing vaccine adoption and government-led awareness campaigns promoting immunization are major factors supporting market growth. Additionally, growing R&D efforts by leading pharmaceutical companies to develop a universal influenza vaccine are expected to further propel the market during the forecast period (2025-2032).

DelveInsight's "Influenza Vaccine Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Influenza Vaccine companies actively working in the market.

To know more about why North America is leading the market growth in the Influenza Vaccine market, get a snapshot of the report Influenza Vaccine Market Trends
https://www.delveinsight.com/sample-request/influenza-vaccine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Influenza Vaccine Overview
An influenza vaccine is a biological preparation designed to protect against the influenza (flu) virus. It stimulates the body's immune system to produce antibodies that recognize and fight specific strains of the virus. Flu vaccines are typically updated each year to match circulating virus variants and are available in several forms, including inactivated (killed virus) and live attenuated (weakened virus) types. Annual vaccination is recommended for most individuals, especially high-risk groups such as young children, the elderly, and people with chronic health conditions, to reduce flu-related illness, hospitalization, and mortality.

DelveInsight Analysis: The influenza vaccine market size was valued at USD 8,247.44 million in 2024 and is projected to grow at a CAGR of 6.87% from 2025 to 2032, reaching approximately USD 13,950.82 million by 2032.

Influenza Vaccine Market Insights
Geographically, North America is projected to hold the largest share of the influenza vaccine market in 2024, driven by the increasing incidence of influenza cases and strong government initiatives promoting vaccination programs. These factors collectively contribute to the region's dominant position and market growth.

To read more about the latest highlights related to Influenza Vaccine, get a snapshot of the key highlights entailed in the Influenza Vaccine Insights
https://www.delveinsight.com/report-store/influenza-vaccine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Recent Developments in the Influenza Vaccine Market Report
• In April 2024, CureVac SE, announced the commencement of Phase 1 for a collaborative venture with GSK marking the initiation of a combined Phase 1/2 investigation into an experimental pre-pandemic vaccine targeting influenza A (H5N1). This is a monovalent vaccine candidate based on mRNA technology and encodes an influenza A H5-antigen.
• In October 2023, Moderna, Inc. announced the interim findings from the Phase 1/2 trial of mRNA-1083, a potential combination vaccine addressing both influenza and COVID-19, have been reported as favorable. mRNA-1083 showed a strong immunogenicity and safety profile against influenza.
• Thus, owing to such developments in the market, rapid growth will be observed in the Influenza Vaccine market during the forecast period

Key Players in the Influenza Vaccine Market
Some of the key market players operating in the Influenza Vaccine market include- GSK plc, Pfizer Inc., BioNTech, SINOVAC, Moderna, Inc., Merck & Co., Inc., Sanofi, AstraZeneca, CSL, Abbott, Novavax, Gilead Sciences, Inc., Serum Institute Of India Pvt. Ltd., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, Cadila Pharmaceuticals, Boehringer Ingelheim International GmbH, Zydus Pharmaceuticals, Inc., Panacea Biotec, Bharat Biotech, and others.

Which MedTech key players in the Influenza Vaccine market are set to emerge as the trendsetter explore @ Key Influenza Vaccine Companies
https://www.delveinsight.com/sample-request/influenza-vaccine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Analysis on the Influenza Vaccine Market Landscape
Inactivated vaccines offer higher stability and a lower risk of mutation compared to live vaccines, making them more suitable for storage and transportation due to their resistance to temperature variations. These vaccines have a strong safety profile and effectively trigger the immune system to generate antibodies against four different strains of the influenza virus.
As a result, the superior efficacy, safety, and stability of inactivated influenza vaccines are expected to significantly support segment growth, thereby driving the overall expansion of the influenza vaccine market throughout the forecast period.

Scope of the Influenza Vaccine Market Report
• Coverage: Global
• Study Period: 2022-2032
• Influenza Vaccine Market Segmentation By Type: Inactivated Influenza Vaccine, Recombinant Influenza Vaccine, and Live Attenuated Influenza Vaccine
• Influenza Vaccine Market Segmentation By Valency: Trivalent, Quadrivalent
• Influenza Vaccine Market Segmentation By Manufacturing Process: Egg-based Vaccine, Cell Culture-based Vaccine
• Influenza Vaccine Market Segmentation By Route of Administration: Nasal, Systemic
• Influenza Vaccine Market Segmentation By Distribution Channel: Hospital and Retail Pharmacy, Government Agencies
• Influenza Vaccine Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Influenza Vaccine Companies: GSK plc, Pfizer Inc., BioNTech, SINOVAC, Moderna, Inc., Merck & Co., Inc., Sanofi, AstraZeneca, CSL, Abbott, Novavax, Gilead Sciences, Inc., Serum Institute Of India Pvt. Ltd., DAIICHI SANKYO COMPANY, LIMITED, Novartis AG, Cadila Pharmaceuticals, Boehringer Ingelheim International GmbH, Zydus Pharmaceuticals, Inc., Panacea Biotec, Bharat Biotech, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View

Interested in knowing how the Influenza Vaccine market will grow by 2032? Click to get a snapshot of the Influenza Vaccine Market Analysis
https://www.delveinsight.com/sample-request/influenza-vaccine-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr

Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.

This release was published on openPR.